Natural Insulin Sensitisers — Evidence-Based Compounds
Insulin signalling through IRS-1/PI3K/Akt drives glucose uptake into cells — its dysregulation underlies type 2 diabetes, metabolic syndrome, PCOS, and accelerated aging.
Insulin resistance — impaired cellular response to insulin signalling — is the metabolic dysfunction underlying type 2 diabetes, obesity, PCOS, and many cardiovascular conditions. Compounds that improve insulin sensitivity work through GLUT4 translocation, AMPK activation, PPAR-γ modulation, or reduction of inflammatory interference with IRS-1. The following are ranked by evidence from the BiohacksAI corpus.
Rankings based on BiohacksAI discovery score, target match with INSR, IRS1, PIK3CA, pathway overlap, and PubMed study count. All data is deterministic and corpus-verified. Not medical advice.
All mechanisms · Browse all compounds · Biological pathways · Health conditions
Data: PubMed/NCBI, BindingDB, Reactome. © Organiq Sweden AB · Patent pending EVE-PAT-2026-001